396 related articles for article (PubMed ID: 30002112)
1.
Kesler M; Levine C; Hershkovitz D; Mishani E; Menachem Y; Lerman H; Zohar Y; Shibolet O; Even-Sapir E
J Nucl Med; 2019 Feb; 60(2):185-191. PubMed ID: 30002112
[No Abstract] [Full Text] [Related]
2. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
3.
Gündoğan C; Ergül N; Çakır MS; Kılıçkesmez Ö; Gürsu RU; Aksoy T; Çermik TF
Mol Imaging Radionucl Ther; 2021 Jun; 30(2):79-85. PubMed ID: 34082503
[TBL] [Abstract][Full Text] [Related]
4. Comparison of PET imaging of activated fibroblasts and
Shi X; Xing H; Yang X; Li F; Yao S; Congwei J; Zhao H; Hacker M; Huo L; Li X
Eur J Nucl Med Mol Imaging; 2021 May; 48(5):1593-1603. PubMed ID: 33097975
[TBL] [Abstract][Full Text] [Related]
5. [
Kunikowska J; Cieślak B; Gierej B; Patkowski W; Kraj L; Kotulski M; Zieniewicz K; Królicki L
Eur J Nucl Med Mol Imaging; 2021 Mar; 48(3):883-892. PubMed ID: 32885272
[TBL] [Abstract][Full Text] [Related]
6. [
Lin R; Wang C; Chen S; Lin T; Cai H; Chen S; Yang Y; Zhang J; Xu F; Zhang J; Chen X; Zang J; Miao W
Eur J Nucl Med Mol Imaging; 2024 Jan; 51(2):535-547. PubMed ID: 37728667
[TBL] [Abstract][Full Text] [Related]
7. Evidence of Prostate-Specific Membrane Antigen Expression in Hepatocellular Carcinoma Using 68Ga-PSMA PET/CT.
Kuyumcu S; Has-Simsek D; Iliaz R; Sanli Y; Buyukkaya F; Akyuz F; Turkmen C
Clin Nucl Med; 2019 Sep; 44(9):702-706. PubMed ID: 31348076
[TBL] [Abstract][Full Text] [Related]
8. A prospective study of
Shamim SA; Kumar N; Arora G; Jaswal S; Shalimar ; Gamanagatti S; Bal C
Ann Nucl Med; 2024 Feb; 38(2):103-111. PubMed ID: 37926772
[TBL] [Abstract][Full Text] [Related]
9. Comparative Findings Between
Erhamamcı S; Aslan N
Mol Imaging Radionucl Ther; 2020 Oct; 29(3):135-138. PubMed ID: 33094578
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic Value of 68Ga PSMA-11 PET/CT Imaging of Brain Tumors-Preliminary Analysis.
Sasikumar A; Joy A; Pillai MR; Nanabala R; Anees K M; Jayaprakash PG; Madhavan J; Nair S
Clin Nucl Med; 2017 Jan; 42(1):e41-e48. PubMed ID: 27846000
[TBL] [Abstract][Full Text] [Related]
11. PET imaging of hepatocellular carcinoma by targeting tumor-associated endothelium using [
Lu Q; Long Y; Fan K; Shen Z; Gai Y; Liu Q; Jiang D; Cai W; Wan C; Lan X
Eur J Nucl Med Mol Imaging; 2022 Oct; 49(12):4000-4013. PubMed ID: 35763056
[TBL] [Abstract][Full Text] [Related]
12. Combined Early and Late [
Hohberg M; Kobe C; Täger P; Hammes J; Schmidt M; Dietlein F; Wild M; Heidenreich A; Drzezga A; Dietlein M
Mol Imaging Biol; 2019 Jun; 21(3):558-566. PubMed ID: 30105521
[TBL] [Abstract][Full Text] [Related]
13.
Wang H; Zhu W; Ren S; Kong Y; Huang Q; Zhao J; Guan Y; Jia H; Chen J; Lu L; Xie F; Qin L
Front Oncol; 2021; 11():693640. PubMed ID: 34249748
[TBL] [Abstract][Full Text] [Related]
14. Head-to-head comparisons of
Lin BH; Chen SH; Chen SM; Qiu QR; Gao RC; Wei Y; Zheng QS; Miao WB; Xu N
Int Urol Nephrol; 2023 Nov; 55(11):2753-2764. PubMed ID: 37477778
[TBL] [Abstract][Full Text] [Related]
15. Intra-Individual Comparison of 18F-PSMA-1007 and 18F-FDG PET/CT in the Evaluation of Patients With Prostate Cancer.
Zhou X; Li Y; Jiang X; Wang X; Chen S; Shen T; You J; Lu H; Liao H; Li Z; Cheng Z
Front Oncol; 2020; 10():585213. PubMed ID: 33604285
[TBL] [Abstract][Full Text] [Related]
16. Multiparametric dynamic whole-body PSMA PET/CT using [
Dias AH; Jochumsen MR; Zacho HD; Munk OL; Gormsen LC
EJNMMI Res; 2023 Apr; 13(1):31. PubMed ID: 37060394
[TBL] [Abstract][Full Text] [Related]
17. Head-to-head comparison of [
Souza SPM; Frasson FC; Takahashi MES; Duarte GBO; Castro VP; Pericole FV; Velloso LA; De Souza CA; Lorand-Metze I; Santos AO; Ramos CD
Eur J Nucl Med Mol Imaging; 2023 Jul; 50(8):2432-2440. PubMed ID: 36988710
[TBL] [Abstract][Full Text] [Related]
18. Prostate-Specific Membrane Antigen in Anaplastic and Poorly Differentiated Thyroid Cancer-A New Diagnostic and Therapeutic Target?
Wächter S; Di Fazio P; Maurer E; Manoharan J; Keber C; Pfestroff A; Librizzi D; Bartsch DK; Luster M; Eilsberger F
Cancers (Basel); 2021 Nov; 13(22):. PubMed ID: 34830843
[TBL] [Abstract][Full Text] [Related]
19. Use of
Shi Y; Xu L; Zhu Y; Wang Y; Chen R; Liu J
Front Oncol; 2021; 11():646110. PubMed ID: 33777806
[TBL] [Abstract][Full Text] [Related]
20. A pilot study of
Wang G; Zhou M; Zang J; Jiang Y; Chen X; Zhu Z; Chen X
EJNMMI Res; 2022 Aug; 12(1):52. PubMed ID: 35984529
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]